STAT+: Pharmalittle: We’re reading about concerns over a rare disease drug, pharma payments to docs, and more
STAT News · LC · trust 42/100
Patient advocates and some experts are expressing growing alarm over the perceived risks of a Neurocrine Biosciences rare disease drug
Read the original at STAT News →
Open in TruthVane →